glp 1 type 2 diabetes GLP-1RAs Reduce External Eating Behavior with Dual GIP/GLP-1 receptor agonists: New
Description
30-day metabolic reset program with GLP-1 support

Background Since the SUSTAIN-6 trial, which noted early worsening of retinopathy with semaglutide (HR 1.76

Results The primary analysis assessing the association between GLP-1 RA use and GRC or aspiration events included 20 retrospective studies with a total of 207,708 patients (23,366 GLP-1 RA users)

It's classic drug repurposing, a technique that saved lives during COVID.

Its time that we change the way we treat type 2 diabetes

Ozempic vs Mounjaro: which GLP-1 delivers more weight loss
